We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

Results: 3

1.
Figure 2

Figure 2. From: HIGH PROBABILITY OF LONG-TERM SURVIVAL IN 2-YEAR SURVIVORS OF AUTOLOGOUS HEMATOPOIETIC CELL TRANSPLANTATION FOR ACUTE MYELOID LEUKEMIA IN FIRST OR SECOND COMPLETE REMISSION.

Non-relapse mortality among patients surviving in remission for at least 2-years after autologous hematopoietic-cell transplant for acute myeloid leukemia (by disease status at transplant)

Navneet S. Majhail, et al. Bone Marrow Transplant. ;46(3):385-392.
2.
Figure 1

Figure 1. From: HIGH PROBABILITY OF LONG-TERM SURVIVAL IN 2-YEAR SURVIVORS OF AUTOLOGOUS HEMATOPOIETIC CELL TRANSPLANTATION FOR ACUTE MYELOID LEUKEMIA IN FIRST OR SECOND COMPLETE REMISSION.

Overall survival of patients surviving in remission for at least 2-years after autologous hematopoietic-cell transplant for acute myeloid leukemia (by disease status at transplant)

Navneet S. Majhail, et al. Bone Marrow Transplant. ;46(3):385-392.
3.
Figure 3

Figure 3. From: HIGH PROBABILITY OF LONG-TERM SURVIVAL IN 2-YEAR SURVIVORS OF AUTOLOGOUS HEMATOPOIETIC CELL TRANSPLANTATION FOR ACUTE MYELOID LEUKEMIA IN FIRST OR SECOND COMPLETE REMISSION.

Relative excess mortality (solid line) compared to age-, gender- and race- matched general population for patients surviving in remission for at least 2-years after autologous hematopoietic-cell transplant for acute myeloid leukemia. A relative risk of 1 indicates that the mortality rate of the population of interest is similar to that of the general population. Dashed lines represent 95% pointwise confidence intervals. The population mortality rate is the same as that in our study cohort whenever the upper and lower 95% confidence bands include 1 in between them. From 4 years after transplantation, there was no difference in mortality rates between our study cohort and the matched general population. The confidence bands widen over time as fewer patients are at risk.

Navneet S. Majhail, et al. Bone Marrow Transplant. ;46(3):385-392.

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Write to the Help Desk